Open Content

Subscribe today for access to
Articles and Reports

By Glenn S. Demby | Sep 21, 2023 | 2 min read

The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.

By Rachel Muenz | Sep 21, 2023 | 1 min read

Billing and coding consultant Diana Voorhees shares her tips to ensure compliance when billing laboratory services.

By Rachel Muenz | Sep 6, 2023 | 2 min read

The FDA recently submitted its own proposed rule relating to lab-developed test regulation for review.

By Glenn S. Demby | Feb 22, 2023 | 2 min read

Not disclosing list prices of uncovered lab tests on ABN is not consumer fraud, court says.

By Rachel Muenz | Feb 15, 2023 | 2 min read

Though last week’s cases didn’t involve labs or lab testing, most were FCA-related issues including inflated claims.

By Glenn S. Demby | Feb 15, 2023 | 3 min read

Specially crafted lab tests speed up adoption of novel drug treatments.

By Rachel Muenz | Feb 14, 2023 | 2 min read

Q4 2022 financial results released by three key lab companies over the past week mainly included losses, but there were positives as well.

By Glenn S. Demby | Feb 13, 2023 | 3 min read

Influential panel cites lack of evidence of tests’ harms and benefits.

By Rachel Muenz | Feb 8, 2023 | 3 min read

Last week saw the usual False Claims Act and kickback-related charges, with the biggest action involving urine drug testing.

By Glenn S. Demby | Feb 8, 2023 | 3 min read

FDA will still be able to issue EUAs for COVID-19 tests after May 11.

By Rachel Muenz | Feb 7, 2023 | 3 min read

A new method of early, multi-cancer detection could prove more effective for non-invasive screening than other emerging options.

By Glenn S. Demby | Feb 6, 2023 | 4 min read

Cost cutting and restructuring has become the order of the day for many lab companies.

By Rachel Muenz | Feb 1, 2023 | 2 min read

While AI as a diagnostic tool is still years away from regular clinical use, recent research is an important step.